197 related articles for article (PubMed ID: 34445291)
1. Chlorogenic Acid Enhances Doxorubicin-Mediated Cytotoxic Effect in Osteosarcoma Cells.
Salzillo A; Ragone A; Spina A; Naviglio S; Sapio L
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445291
[TBL] [Abstract][Full Text] [Related]
2. Chlorogenic acid activates ERK1/2 and inhibits proliferation of osteosarcoma cells.
Sapio L; Salzillo A; Illiano M; Ragone A; Spina A; Chiosi E; Pacifico S; Catauro M; Naviglio S
J Cell Physiol; 2020 Apr; 235(4):3741-3752. PubMed ID: 31602671
[TBL] [Abstract][Full Text] [Related]
3. Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death.
Chiosi E; Spina A; Sorrentino A; Romano M; Sorvillo L; Senatore G; D'Auria R; Abbruzzese A; Caraglia M; Naviglio S; Illiano G
J Interferon Cytokine Res; 2007 Jul; 27(7):589-97. PubMed ID: 17651020
[TBL] [Abstract][Full Text] [Related]
4. Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells.
Spina A; Sorvillo L; Chiosi E; Esposito A; Di Maiolo F; Sapio L; Caraglia M; Naviglio S
Oncol Rep; 2013 May; 29(5):1689-96. PubMed ID: 23446517
[TBL] [Abstract][Full Text] [Related]
5. Anti-oxidant effect of bergamot polyphenolic fraction counteracts doxorubicin-induced cardiomyopathy: Role of autophagy and c-kit
Carresi C; Musolino V; Gliozzi M; Maiuolo J; Mollace R; Nucera S; Maretta A; Sergi D; Muscoli S; Gratteri S; Palma E; Bosco F; Giancotta C; Muscoli C; Marino F; Aquila I; Torella D; Romeo F; Mollace V
J Mol Cell Cardiol; 2018 Jun; 119():10-18. PubMed ID: 29654879
[TBL] [Abstract][Full Text] [Related]
6. Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity.
Rocca C; Scavello F; Colombo B; Gasparri AM; Dallatomasina A; Granieri MC; Amelio D; Pasqua T; Cerra MC; Tota B; Corti A; Angelone T
FASEB J; 2019 Jun; 33(6):7734-7747. PubMed ID: 30973759
[TBL] [Abstract][Full Text] [Related]
7. Vanillin Prevents Doxorubicin-Induced Apoptosis and Oxidative Stress in Rat H9c2 Cardiomyocytes.
Sirangelo I; Sapio L; Ragone A; Naviglio S; Iannuzzi C; Barone D; Giordano A; Borriello M
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32752227
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S
Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388
[TBL] [Abstract][Full Text] [Related]
9. Chlorogenic acid: A potent molecule that protects cardiomyocytes from TNF-α-induced injury via inhibiting NF-κB and JNK signals.
Tian L; Su CP; Wang Q; Wu FJ; Bai R; Zhang HM; Liu JY; Lu WJ; Wang W; Lan F; Guo SZ
J Cell Mol Med; 2019 Jul; 23(7):4666-4678. PubMed ID: 31033175
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.
Murahari S; Jalkanen AL; Kulp SK; Chen CS; Modiano JF; London CA; Kisseberth WC
BMC Cancer; 2017 Jan; 17(1):67. PubMed ID: 28109246
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of the metabolic modulator Metformin on osteosarcoma cancer stem-like cells.
Paiva-Oliveira DI; Martins-Neves SR; Abrunhosa AJ; Fontes-Ribeiro C; Gomes CMF
Cancer Chemother Pharmacol; 2018 Jan; 81(1):49-63. PubMed ID: 29086064
[TBL] [Abstract][Full Text] [Related]
13. Targeting inflammatory kinase as an adjuvant treatment for osteosarcomas.
Noh K; Kim KO; Patel NR; Staples JR; Minematsu H; Nair K; Lee FY
J Bone Joint Surg Am; 2011 Apr; 93(8):723-32. PubMed ID: 21508279
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment of human osteosarcoma cells with N-methylformamide enhances P-glycoprotein expression and resistance to doxorubicin.
Scotlandi K; Serra M; Manara MC; Lollini PL; Maurici D; Del Bufalo D; Baldini N
Int J Cancer; 1994 Jul; 58(1):95-101. PubMed ID: 7912235
[TBL] [Abstract][Full Text] [Related]
15. Hesperetin-etoposide combinations induce cytotoxicity in U2OS cells: Implications on therapeutic developments for osteosarcoma.
Coutinho L; Oliveira H; Pacheco AR; Almeida L; Pimentel F; Santos C; Ferreira de Oliveira JM
DNA Repair (Amst); 2017 Feb; 50():36-42. PubMed ID: 28063664
[TBL] [Abstract][Full Text] [Related]
16. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
Dieudonné FX; Marion A; Marie PJ; Modrowski D
J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
[TBL] [Abstract][Full Text] [Related]
17. Chlorogenic acid inhibits osteosarcoma carcinogenesis via suppressing the STAT3/Snail pathway.
Zhang F; Yin G; Han X; Jiang X; Bao Z
J Cell Biochem; 2019 Jun; 120(6):10342-10350. PubMed ID: 30582213
[TBL] [Abstract][Full Text] [Related]
18. Liposomal short-chain C6 ceramide induces potent anti-osteosarcoma activity in vitro and in vivo.
Zhai L; Sun N; Han Z; Jin HC; Zhang B
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):274-80. PubMed ID: 26505795
[TBL] [Abstract][Full Text] [Related]
19. Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity.
Bamodu OA; Huang WC; Tzeng DT; Wu A; Wang LS; Yeh CT; Chao TY
Cancer Lett; 2015 Aug; 364(2):125-34. PubMed ID: 25976769
[TBL] [Abstract][Full Text] [Related]
20. H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
Chegaev K; Rolando B; Cortese D; Gazzano E; Buondonno I; Lazzarato L; Fanelli M; Hattinger CM; Serra M; Riganti C; Fruttero R; Ghigo D; Gasco A
J Med Chem; 2016 May; 59(10):4881-9. PubMed ID: 27120394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
